Impact of Coxiella burnetii Antibodies on Pregnancy Outcomes
Author Information
Author(s): Wim van der Hoek, Jamie C.E. Meekelenkamp, Alexander C.A.P. Leenders, Nancy Wijers, Daan W. Notermans, Chantal W.P.M. Hukkelhoven
Primary Institution: Centre for Infectious Disease Control, National Institute for Public Health and the Environment
Hypothesis
Does the presence of antibodies against Coxiella burnetii during early pregnancy affect pregnancy outcomes?
Conclusion
The study found no evidence of adverse pregnancy outcomes among women with antibodies to C. burnetii during early pregnancy.
Supporting Evidence
- The presence of antibodies was not significantly associated with preterm delivery or low birth weight.
- The study analyzed data from 1174 women linked to the Netherlands Perinatal Registry.
- No adverse pregnancy outcomes were observed in women with antibodies against C. burnetii.
Takeaway
The study looked at pregnant women with a certain infection and found that it didn't seem to harm their babies.
Methodology
The study analyzed serum samples from pregnant women and linked them to pregnancy outcomes recorded in the Netherlands Perinatal Registry.
Potential Biases
Potential bias due to the inability to link some serum samples to pregnancy outcomes.
Limitations
The study had a lower than expected seroprevalence and some samples could not be linked to corresponding pregnancy outcome data.
Participant Demographics
The study included pregnant women from the high incidence area of Q fever in the Netherlands.
Statistical Information
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website